Bibliography
Export 1 results:
Filters: Keyword is Complement C5a/im [Immunology] [Clear All Filters]
Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusion. Transfusion//Transfusion. 2015;55(3):605-10.